Vascular endothelial growth factor gene variability is associated with increased risk for AD
β Scribed by Roberto Del Bo; Marina Scarlato; Serena Ghezzi; Filippo Martinelli Boneschi; Chiara Fenoglio; Sara Galbiati; Roberta Virgilio; Daniela Galimberti; Gloria Galimberti; Marco Crimi; Carlo Ferrarese; Elio Scarpini; Nereo Bresolin; Giacomo P. Comi
- Publisher
- John Wiley and Sons
- Year
- 2005
- Tongue
- English
- Weight
- 174 KB
- Volume
- 57
- Category
- Article
- ISSN
- 0364-5134
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract A common 936 C/T polymorphism in the gene for the vascular endothelial growth factor (VEGF) has been associated with VEGF plasma levels. In our caseβcontrol study, we investigated the role of this polymorphism for breast cancer risk. VEGF genotype was determined in 500 women with breast
## Abstract ## BACKGROUND Vascular endothelial growth factor (VEGF) is a mediator of angiogenesis and is associated with a poor prognosis in patients with primary breast carcinoma. In the current study, the authors investigated whether there was an association between VEGF levels in tumor tissues
## Eighteen-Year Results in the Treatment of Early Breast Carcinoma with Mastectomy Versus Breast Conservation Therapy W e applaud the recent report by Poggi et al. 1 regarding the 18-year follow-up data of the National Cancer Institute randomized trial on breast conservation therapy (BCT) versus